Drawing for Serial No. 79390896

USPTO serial 79390896

Serial No. 79390896

Reviewed by CopyMark Law Group

Reg. 7691423Status 700Registered
Filing date
Status date
Registration date
Feb 18, 2025
Examiner
BUSH, KAREN K
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79390896?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amy L. Wright

Amy L. Wright Taft Stettinius & Hollister LLPOne Indiana SquareSuite 3500INDIANAPOLIS, IN 46204

Goods and services

ClassDescriptionStatusFirst use
009Computers, computer hardware and computer peripheral devices; computer software; computer application software; application software for mobile devices, all of the aforesaid being downloadable or recorded and for the purpose of accessing, navigating, analysing, updating and identifying regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; Computer software; computer application software; application software for mobile devices, all of the aforesaid being downloadable or recorded and for the purpose of delivering training and educational content in respect of regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; downloadable and recorded computer software for generating reports concerning regulatory requirements in the medical and life sciences industries; downloadable and recorded computer software for delivering training in relation to regulatory requirements in the medical and life sciences industries; downloadable publications, namely, magazines, newsletters, periodicals and brochures, all in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; downloadable and recorded media including written, image, video, audio and visual content, and infographics, namely, e-books, CDs, DVDs, audio and video recordings, digital image files, podcasts and webinars in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; downloadable educational materials, namely, books, audiobooks, textbooks, brochures and video and audio recordings in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; downloadable electronic educational materials; downloadable data sets; downloadable data sets relating to regulatory compliance in the medical and life sciences industriesACTIVE—
035Advertising; business management, organization and administration; providng office functions; market research, prospecting and analysis; collection, compilation, analysis, reporting and dissemination of statistics, data and information; marketing assistance and consultancy; business consultancy services relating to the supply of quality management systems; consultancy relating to data processing; business consulting services in the medical and life sciences industries; business advisory, development, and strategic planning services provided to companies for business purposes in the medical and life sciences industries; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission business management, in the nature of administrative assistance, namely, assisting others in preparing and filing applications for regulatory approval of medical devices, medical technologies, medications, pharmaceuticals, and biotechnology; providing information online regarding regulatory submission business management in the nature of administrative assistance; commercial consultancy relating to the development and marketing of medical apparatus and devices; advice on the implementation of communication strategies relating to medical devices; business and advisory consultancy services relating to obtaining and maintaining commercial product certifications.ACTIVE—
041Education services, namely, providing training courses, online and live classes, seminars, webinars, workshops and tutorials in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; providing of training in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; education services in the medical and life sciences industries; educational services in relation to regulatory compliance, issues, updates and developments; educational services in relation to good practice compliance, risk management, design control, quality management solutions, standard operating procedures, data integrity, unique device identification and regulatory readiness; education and training in relation to compliance and legal aspects of the European union in vitro diagnostic regulation; education services relating to quality services in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; legal education services; publication of instructional literature; publishing, reporting, and writing of texts, other than publicity texts; arranging and conducting conferences, workshops, seminars, symposia, competitions, conventions and meetings in the medical and life sciences industries; writing, reporting and publication of non-downloadable guidelines, reports, data and case studies relating to the medical and life sciences industries; advisory and consultancy services relating to all above mentioned services.ACTIVE—
042Scientific, technological and industrial analysis, research and design services in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; conducting and designing clinical trials for others; laboratory testing of materials; consultancy services related to laboratory testing of materials; clinical research in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; biological research and medical research; site monitoring services; analysis and evaluation of product development; analysis and evaluation of product design; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical product evaluation; product quality evaluation; quality control services for others; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the medical and life sciences industries; scientific research, analysis, testing, and related scientific studies in the medical and life sciences industries; consulting services in the medical and life sciences industries; biotechnology, biotechnology research consulting services; pharmaceutical research and product development for use in manufacturing; consulting services for others in the field of designing pre-clinical and clinical studies and trials for others; technical writing; technical writing for others; testing, analysis and evaluation of the services of others for the purpose of certification; testing of apparatus in the field of medical devices for certification purposes; electronic data storage; software as a service [SaaS] for the purpose of accessing, navigating, analysing, updating and identifying regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; software as a service [SaaS] for the purpose delivering training, educational content and reports in respect of regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; providing online, non-downloadable software for the purpose of accessing, navigating, analysing, updating and identifying regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; providing online, non-downloadable software for the purpose delivering training, educational content and reports in respect of regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; software design, development and engineering; computer software consultancy; providing online, non-downloadable software for generating reports concerning regulatory requirements in the medical and life sciences industries; providing online, non-downloadable software for delivering training in relation to regulatory requirements in the medical and life sciences industries; information, consultancy and advisory services relating to all above mentioned services.ACTIVE—
044Clinical medical consultation services; medical information; professional consultancy relating to health care; advisory services relating to medical and surgical instruments and devices; consulting and advisory services relating to obtaining and maintaining commercial product certifications for medical and surgical instruments and devices; consultancy and information services relating to medical, pharmaceutical and biopharmaceutical products; consulting and advisory services relating to the European union in vitro diagnostic regulation (IVDR); consulting and advisory services relating to the European union medical device regulation (MDR); consulting and advisory services relating to medical aspects of the European union in vitro diagnostic regulation (IVDR); consulting and advisory services relating to medical aspects of the European union medical device regulation (MDR); preparation of reports relating to medical matters; preparation of clinical and performance evaluation reports; preparation of clinical and performance evaluation reports for medical devices; information, consultancy and advisory services relating to all above mentioned services.ACTIVE—
045Legal services; regulatory and legal compliance auditing; advisory services relating to regulatory affairs; expert consultancy relating to legal issues regulatory compliance consulting services in the life sciences fields; regulatory compliance consulting services in the life sciences fields namely, reviewing standards and practices to assist others with compliance with governmental laws, regulations and rules pertaining to medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; consulting and advisory services relating to legal aspects of the European Union In vitro Diagnostic Regulation (IVDR); consulting and advisory services relating to legal aspects of the European Union Medical Device Regulation (MDR); legal support services; information, consultancy and advisory services relating to all above mentioned services.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 29, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 19, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 2, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 1, 2025FIMPFINAL DISPOSITION PROCESSED—
Aug 22, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 6, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 6, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 19, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 31, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 31, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 25, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 5, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 15, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Nov 15, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 15, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 15, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 29, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 29, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 29, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 28, 2024RFNTREFUSAL PROCESSED BY IB—
Apr 30, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 30, 2024RFRRREFUSAL PROCESSED BY MPU—
Apr 24, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 20, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 19, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2024DOCKASSIGNED TO EXAMINER—
Mar 13, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 7, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance